BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32385139)

  • 1. Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated with PIPAC.
    Nielsen M; Graversen M; Ellebæk SB; Kristensen TK; Fristrup C; Pfeiffer P; Mortensen MB; Detlefsen S
    J Clin Pathol; 2021 Jan; 74(1):19-24. PubMed ID: 32385139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of biopsy site selection for peritoneal regression grading score (PRGS) in peritoneal metastasis treated with repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC).
    Fallah M; Detlefsen S; Ainsworth AP; Fristrup CW; Mortensen MB; Pfeiffer P; Tarpgaard LS; Graversen M
    Pleura Peritoneum; 2022 Sep; 7(3):143-148. PubMed ID: 36159216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study.
    Ellebæk SB; Graversen M; Detlefsen S; Lundell L; Fristrup CW; Pfeiffer P; Mortensen MB
    Clin Exp Metastasis; 2020 Apr; 37(2):325-332. PubMed ID: 32002724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
    Tempfer CB; Hilal Z; Dogan A; Petersen M; Rezniczek GA
    Eur J Surg Oncol; 2018 Jul; 44(7):1112-1117. PubMed ID: 29753612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC).
    Graversen M; Detlefsen S; Bjerregaard JK; Pfeiffer P; Mortensen MB
    Clin Exp Metastasis; 2017 Jun; 34(5):309-314. PubMed ID: 28516306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of free intraperitoneal tumour cells in peritoneal lavage fluid from patients with peritoneal metastasis before and after treatment with pressurised intraperitoneal aerosol chemotherapy (PIPAC).
    Graversen M; Fristrup C; Kristensen TK; Larsen TR; Pfeiffer P; Mortensen MB; Detlefsen S
    J Clin Pathol; 2019 May; 72(5):368-372. PubMed ID: 30755498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducibility of the peritoneal regression grading score for assessment of response to therapy in peritoneal metastasis.
    Solass W; Sempoux C; Carr NJ; Bibeau F; Neureiter D; Jäger T; Di Caterino T; Brunel C; Klieser E; Fristrup CW; Mortensen MB; Detlefsen S
    Histopathology; 2019 Jun; 74(7):1014-1024. PubMed ID: 30687944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of combined progression index based on peritoneal grading regression score and peritoneal cytology in peritoneal metastasis.
    Benzerdjeb N; Durieux E; Tantot J; Isaac S; Fontaine J; Harou O; Glehen O; Kepenekian V; Alyami M; Villeneuve L; Laplace N; Traverse-Glehen A; Shisheboran-Devouassoux M; Bakrin N
    Histopathology; 2020 Oct; 77(4):548-559. PubMed ID: 32060943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pressurized IntraPeritoneal Aerosol Chemotherapy with one minute of electrostatic precipitation (ePIPAC) is feasible, but the histological tumor response in peritoneal metastasis is insufficient.
    Graversen M; Detlefsen S; Ellebaek SB; Fristrup C; Pfeiffer P; Mortensen MB
    Eur J Surg Oncol; 2020 Jan; 46(1):155-159. PubMed ID: 31493986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No Renal Toxicity After Repeated Treatment with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Unresectable Peritoneal Metastasis.
    Larbre V; Alyami M; Mercier F; Vantard N; Bonnefoy I; Opsomer MA; Villeneuve L; Bakrin N; Rioufol C; Glehen O; Kepenekian V
    Anticancer Res; 2018 Dec; 38(12):6869-6875. PubMed ID: 30504403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis.
    Di Giorgio A; Schena CA; El Halabieh MA; Abatini C; Vita E; Strippoli A; Inzani F; Rodolfino E; Romanò B; Pacelli F; Rotolo S
    Surg Oncol; 2020 Sep; 34():270-275. PubMed ID: 32891341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastases in Solid Organ Graft Recipients: First Experience.
    Horvath P; Yurttas C; Struller F; Bösmüller H; Lauer UM; Nadalin S; Königsrainer A; Reymond MA
    Ann Transplant; 2019 Jan; 24():30-35. PubMed ID: 30643112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastases of pancreas and biliary tract cancer.
    Horvath P; Beckert S; Struller F; Königsrainer A; Reymond MA
    Clin Exp Metastasis; 2018 Oct; 35(7):635-640. PubMed ID: 30062506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Peritoneal Metastasis with Pressurized Intraperitoneal Aerosol Chemotherapy: Results from the Prospective PIPAC-OPC2 Study.
    Graversen M; Detlefsen S; Ainsworth AP; Fristrup CW; Knudsen AO; Pfeiffer P; Tarpgaard LS; Mortensen MB
    Ann Surg Oncol; 2023 May; 30(5):2634-2644. PubMed ID: 36602663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of immunohistochemistry for interobserver agreement of Peritoneal Regression Grading Score in peritoneal metastasis.
    Detlefsen S; Windedal T; Bibeau F; Bruhn LV; Carr N; Graversen M; Markowski K; Mortensen MB; Neureiter D; Sempoux C; Solass W; Thinesen MT; Fristrup C
    Hum Pathol; 2022 Feb; 120():77-87. PubMed ID: 34954136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis.
    Robella M; Vaira M; De Simone M
    World J Surg Oncol; 2016 Apr; 14():128. PubMed ID: 27125996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis.
    Nadiradze G; Giger-Pabst U; Zieren J; Strumberg D; Solass W; Reymond MA
    J Gastrointest Surg; 2016 Feb; 20(2):367-73. PubMed ID: 26511950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe peritoneal sclerosis after repeated pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC OX): report of two cases and literature survey.
    Graversen M; Detlefsen S; Pfeiffer P; Lundell L; Mortensen MB
    Clin Exp Metastasis; 2018 Mar; 35(3):103-108. PubMed ID: 29705882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer.
    Alyami M; Bonnot PE; Mercier F; Laplace N; Villeneuve L; Passot G; Bakrin N; Kepenekian V; Glehen O
    Eur J Surg Oncol; 2021 Jan; 47(1):123-127. PubMed ID: 32561204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is long-term survival in patients with peritoneal metastasis from gastric, pancreatic, or colorectal cancer? A study of patients treated with systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC).
    Kryh-Jensen CG; Fristrup CW; Ainsworth AP; Detlefsen S; Mortensen MB; Pfeiffer P; Tarpgaard LS; Graversen M
    Pleura Peritoneum; 2023 Dec; 8(4):147-155. PubMed ID: 38144215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.